ProViper

ProViper from Disguised Alpha, built on GHK-Cu (inj/oral). Below: what's in it, whether the active actually reaches the layer it needs to, where it goes in a routine, and what to expect.

Does GHK-Cu (inj/oral) actually work on skin?

This is a different question from whether it works injected, and the answer is often different too — a molecule has to survive the stratum corneum before any of its biology matters. Full GHK-Cu (inj/oral) breakdown →

Human clinical evidence

• The best-evidenced peptide in this section for topical use, and unusually it is evidenced as a topical specifically rather than borrowed from injection studies. Controlled work reports increased collagen and elastin, improved skin firmness and reduced fine lines over 12 weeks in facial creams, and improved wound closure in dermatology settings.

Correlative data

• Decades of use in cosmetic dermatology, and one of very few peptides that survived from prescription wound care into ordinary skincare on the strength of results rather than marketing.
• Scalp use for density is widespread and reported experience is positive but slow — months, not weeks — and far less dramatic than minoxidil.

How the mechanism reads

• A copper-binding tripeptide (glycyl-L-histidyl-L-lysine) at about 340 Da — small enough to actually cross the stratum corneum, which is why it works topically when larger peptides do not. It upregulates collagen I, III and IV and elastin, signals metalloproteinase remodelling, and delivers copper as a cofactor for lysyl oxidase, the enzyme that cross-links collagen.
• The copper is the caveat. It is what makes it work and also what makes it stain, oxidise and interact badly with direct vitamin C in the same layer. Separate them by routine, AM and PM.

Does SYN-AKE actually work on skin?

This is a different question from whether it works injected, and the answer is often different too — a molecule has to survive the stratum corneum before any of its biology matters. Full SYN-AKE breakdown →

Human clinical evidence

• Supplier data only, reporting reduced expression lines. No independent replication of consequence.

Correlative data

• Marketed on its origin story — a synthetic analogue of a peptide from temple viper venom. The story does more work than the data.

How the mechanism reads

• A dipeptide that antagonises the nicotinic acetylcholine receptor post-synaptically, where Argireline and SNAP-8 act pre-synaptically — a different route to the same muscle-relaxation premise.
• And the same ceiling: the target sits below skin that the molecule has to cross first.
• A synthetic mimetic of waglerin-1, a peptide from temple viper venom, proposed to antagonise the nicotinic acetylcholine receptor at the muscle end plate. Different receptor from Argireline's SNARE interference, same downstream idea: less contraction, softer dynamic lines.
• The novelty is genuine and the evidence is the thinnest in this section — supplier data, small panels, no independent replication. It earns a place in a routine as an experiment, not as the active you build the routine around.

How to use ProViper

Step 3 — Serum — thinnest first

PM. A topical neuropeptide product — same delivery ceiling as Argireline and SNAP-8. Sits in the same expression-line category, and it is the thinnest evidence in the section — treat it as the experiment in your routine rather than the backbone of it.

What to expect, and when

Subtle at best, 8+ weeks.

What not to layer with ProViper

• GHK-Cu (inj/oral) + Vitamin C — Copper peptides and direct (L-ascorbic) vitamin C deactivate each other. Not dangerous — just wasteful. Split them: vitamin C in the morning, copper peptide at night.

Where to get ProViper

Other GHK-Cu (inj/oral) products in the Vault

Other SYN-AKE products in the Vault

← Every cosmetic in the Vault · Open the interactive Vault